July/August 2023

NEWS & COLUMNS

6-7 NEWS
Novartis to acquire Chinook for $3.5bn; FDA fast tracks AC Immune’s Alzheimer’s disease vaccine

8-9 NEWS
Genetically altered polio vaccines developed; WHO publishes research agenda for AMR

10-11 DERMATOLOGY NEWS
BMS’ Sotyktu recommended by NICE; EC approves UCB’s Bimzelx for psoriatic arthritis

12 DARWIN'S MEDICINE
Why it’s better to enable the future than to fight it

13 POLICY AND PUBLIC HEALTH
With Merck and BMS first out of the gates, here comes the assault on the Inflation Reduction Act

14 DON'T LOSE SIGHT OF BEHAVIOURAL INSIGHT
If we are being asked to demonstrate ROI, we first need to agree on the value of the outcome

15 INNOVATIVE IMPACT BLOG
The impact of storytelling in effective communication

FEATURES

16-17 RESISTING THE RESISTANCE
How genomics can help us win the fight against AMR

18-19 THE RISE OF BIOLOGICS
Looking at the evolving biological sector and the various capacity challenges that global biopharma companies will have to bridge

20-21 HEALTH AND SOCIAL MEDIA
Could social media drive behaviour change in type 2 diabetes?

22-23 CANNES LIONS 2023
As brands leverage the power of creativity to make a meaningful difference to lives and their businesses, pharma is finally making a splash on the French Riviera

24-25 GENOMIC MEDICINE
How international collaboration could help encourage more diverse data for genomic research and ultimately improve global health

26-32 COMMUNIQUÉ 2023
This year’s Awards, held at the London Grosvenor House Hotel, included 31 categories

18. The rise of biologics